Do we need a regulatory path for HIV post-exposure prophylaxis?
作者信息
Miller Veronica, Schaefer Robin
机构信息
Forum for Collaborative Research, UC Berkeley School of Public Health, Washington, DC, USA.
出版信息
J Int AIDS Soc. 2025 Jun;28 Suppl 1(Suppl 1):e26449. doi: 10.1002/jia2.26449.
Abstract
摘要
相似文献
1
Do we need a regulatory path for HIV post-exposure prophylaxis?我们是否需要一条针对HIV暴露后预防的监管途径？
J Int AIDS Soc. 2025 Jun;28 Suppl 1(Suppl 1):e26449. doi: 10.1002/jia2.26449.
2
Research designs to generate evidence of HIV post-exposure prophylaxis effectiveness for new long-acting agents.旨在为新型长效药物生成HIV暴露后预防有效性证据的研究设计。
J Int AIDS Soc. 2025 Jun;28 Suppl 1(Suppl 1):e26475. doi: 10.1002/jia2.26475.
3
Modelling the impact of initiation delay, duration and prior PrEP on the efficacy of post-exposure prophylaxis containing a tenofovir/emtricitabine backbone.模拟开始延迟、持续时间及既往暴露前预防用药对含替诺福韦/恩曲他滨主干的暴露后预防疗效的影响。
J Int AIDS Soc. 2025 Jun;28 Suppl 1(Suppl 1):e26454. doi: 10.1002/jia2.26454.
4
Optimising HIV pre-exposure prophylaxis and testing strategies in men who have sex with men in Australia, Thailand, and China: a modelling study and cost-effectiveness analysis.在中国、澳大利亚和泰国优化男男性行为者的 HIV 暴露前预防和检测策略：一项建模研究和成本效益分析。
Lancet Glob Health. 2024 Feb;12(2):e243-e256. doi: 10.1016/S2214-109X(23)00536-3.
5
Interventions to reduce harm from continued tobacco use.减少持续吸烟危害的干预措施。
Cochrane Database Syst Rev. 2016 Oct 13;10(10):CD005231. doi: 10.1002/14651858.CD005231.pub3.
6
Online delivery of oral HIV pre- and post-exposure prophylaxis: findings from the ePrEP Kenya pilot.口服艾滋病毒暴露前和暴露后预防药物的在线配送：肯尼亚电子预防试点项目的结果
J Int AIDS Soc. 2025 Jun;28 Suppl 1(Suppl 1):e26468. doi: 10.1002/jia2.26468.
7
Untapped potential of post-exposure prophylaxis in sub-Saharan Africa: a comparative analysis of PEP implementation planning in Kenya, Mozambique, Nigeria, Uganda and Zambia.撒哈拉以南非洲地区暴露后预防的未开发潜力：肯尼亚、莫桑比克、尼日利亚、乌干达和赞比亚暴露后预防实施规划的比较分析。
J Int AIDS Soc. 2025 Jun;28 Suppl 1:e26471. doi: 10.1002/jia2.26471.
8
Antivirals for post-exposure prophylaxis of influenza: a systematic review and network meta-analysis.抗流感病毒药物用于暴露后预防：系统评价和网络荟萃分析。
Lancet. 2024 Aug 24;404(10454):764-772. doi: 10.1016/S0140-6736(24)01357-6.
9
Antiretroviral post-exposure prophylaxis (PEP) for occupational HIV exposure.职业性HIV暴露后的抗逆转录病毒暴露后预防（PEP）。
Cochrane Database Syst Rev. 2007 Jan 24;2007(1):CD002835. doi: 10.1002/14651858.CD002835.pub3.
10
HIV post-exposure prophylaxis in community settings and by lay health workers or through task sharing: a systematic review of effectiveness, case studies, values and preferences, and costs.社区环境中由非专业卫生工作者进行或通过任务分担开展的HIV暴露后预防：有效性、案例研究、价值观与偏好以及成本的系统评价
J Int AIDS Soc. 2025 May;28(5):e26448. doi: 10.1002/jia2.26448.
引用本文的文献
1
HIV Post Exposure Prophylaxis: prospects, opportunities and challenges.艾滋病病毒暴露后预防：前景、机遇与挑战。
J Int AIDS Soc. 2025 Jun;28 Suppl 1(Suppl 1):e26511. doi: 10.1002/jia2.26511.
本文引用的文献
1
Research designs to generate evidence of HIV post-exposure prophylaxis effectiveness for new long-acting agents.旨在为新型长效药物生成HIV暴露后预防有效性证据的研究设计。
J Int AIDS Soc. 2025 Jun;28 Suppl 1(Suppl 1):e26475. doi: 10.1002/jia2.26475.
2
Updated guidelines on HIV post-exposure prophylaxis: continued efforts towards increased accessibility.HIV 暴露后预防指南更新：持续努力提高可及性。
J Int AIDS Soc. 2024 Nov;27(11):e26393. doi: 10.1002/jia2.26393.
3
CDC Clinical Guidelines on the Use of Doxycycline Postexposure Prophylaxis for Bacterial Sexually Transmitted Infection Prevention, United States, 2024.美国疾病预防控制中心 2024 年关于使用多西环素进行细菌性性传播感染预防的暴露后预防临床指南。
MMWR Recomm Rep. 2024 Jun 6;73(2):1-8. doi: 10.15585/mmwr.rr7302a1.
4
Post-exposure prophylaxis to prevent HIV: new drugs, new approaches, and more questions.暴露后预防以预防 HIV：新药、新方法和更多问题。
Lancet HIV. 2023 Dec;10(12):e816-e824. doi: 10.1016/S2352-3018(23)00238-2. Epub 2023 Nov 9.
5
Facilitating Next-Generation Pre-Exposure Prophylaxis Clinical Trials Using HIV Recent Infection Assays: A Consensus Statement from the Forum HIV Prevention Trial Design Project.利用 HIV 近期感染检测促进下一代暴露前预防临床试验：来自论坛 HIV 预防试验设计项目的共识声明。
Clin Pharmacol Ther. 2023 Jul;114(1):29-40. doi: 10.1002/cpt.2830. Epub 2023 Jan 5.
6
BASHH updated position statement on doxycycline as prophylaxis for sexually transmitted infections.英国性健康与艾滋病协会（BASHH）关于强力霉素预防性传播感染的最新立场声明。
Sex Transm Infect. 2022 May;98(3):235-236. doi: 10.1136/sextrans-2022-055425.
7
Differentiating Nonoccupational Postexposure Prophylaxis Seroconverters and Non-Seroconverters in a Community-Based Clinic in Los Angeles, California.在加利福尼亚州洛杉矶的一家社区诊所中区分非职业性暴露后预防血清转化者和非血清转化者。
Open Forum Infect Dis. 2017 Apr 4;4(2):ofx061. doi: 10.1093/ofid/ofx061. eCollection 2017 Spring.
8
Adherence to post-exposure prophylaxis for non-forcible sexual exposure to HIV: a systematic review and meta-analysis.非强制性行为暴露后预防艾滋病病毒的依从性：系统评价和荟萃分析。
AIDS Behav. 2014 Feb;18(2):217-25. doi: 10.1007/s10461-013-0567-0.
9
Adherence to HIV post-exposure prophylaxis in victims of sexual assault: a systematic review and meta-analysis.艾滋病病毒暴露后预防用药在性侵犯受害者中的依从性：系统评价和荟萃分析。
Sex Transm Infect. 2012 Aug;88(5):335-41. doi: 10.1136/sextrans-2011-050371. Epub 2012 Feb 13.
10
Ulipristal acetate: review of the efficacy and safety of a newly approved agent for emergency contraception.醋酸乌利司他：一种新批准的紧急避孕药物的疗效和安全性综述。
Clin Ther. 2012 Jan;34(1):24-36. doi: 10.1016/j.clinthera.2011.11.012. Epub 2011 Dec 9.
Zotero 插件